1024:HKEXREYON Pharmaceutical Co., Ltd. Analysis
Data as of 2026-09-03 - not real-time
HK$33.46
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
At HKD 33.46, Kuaishou Technology shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has lost 22.3% over the past 30 days. Relative strength is 30.8 — approaching oversold — and the MACD signal is bearish. Recent trading has carved out support near HKD 32.52 and resistance around HKD 45.00.
Multiples put this in undervalued territory: 8.0 times earnings against the sector's 16.3. Sell-side targets cluster 45.1% above the current quote. The 1.99% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 45.3%, a beta of 0.32 and a maximum drawdown of 64.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.
Multiples put this in undervalued territory: 8.0 times earnings against the sector's 16.3. Sell-side targets cluster 45.1% above the current quote. The 1.99% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 45.3%, a beta of 0.32 and a maximum drawdown of 64.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.
Top Market Events
Kuaishou Technology Announces Second Quarter and Interim 2026 Unaudited Financial Results
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 54.80
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 8.0 versus sector average of 16.3
- Trading below the 200-day average of 54.80
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 8.0 versus sector average of 16.3
- Analyst targets imply +45.1% versus the current price
- Return on equity of 20.6%
Key Metrics & Analysis
Financial Health
Revenue Growth1.40%
Profit Margin10.92%
P/E Ratio8.0
ROE20.63%
ROA5.48%
Debt/Equity47.44
P/B Ratio1.5
Op. Cash FlowHK$24.0B
Free Cash FlowHK$16.0B
Industry P/E16.3
Technical Analysis
TrendBearish
RSI30.8
SupportHK$32.52
ResistanceHK$45.00
MA 20HK$37.06
MA 50HK$40.86
MA 200HK$54.80
MACDBearish
VolumeDecreasing
Fear & Greed Index94.29
Valuation
Fair ValueHK$59.30
Target PriceHK$48.55
Upside/Downside45.09%
GradeUndervalued
TypeValue
Dividend Yield1.99%
Risk Assessment
Beta0.32
Volatility45.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.